---
title: "Kelly Pharmaceuticals Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/bfb812e9-9be6-5735-8510-b167c648480a
json: https://whiteintel.dev/api/public/dossier/bfb812e9-9be6-5735-8510-b167c648480a
identifier: icij:icijol-80001595
jurisdiction: BM
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# Kelly Pharmaceuticals Limited

**Type:** Organization  
**Jurisdiction:** BM  
**Identifier:** `icij:icijol-80001595`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/bfb812e9-9be6-5735-8510-b167c648480a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/bfb812e9-9be6-5735-8510-b167c648480a  

## Ownership & control

### Holdings / subsidiaries

- **Mundipharma Pharmaceutical Company** (shareholder of) — https://whiteintel.dev/entity/9d9e2fe9-e425-5eb5-a24a-f3303a1b3c84
- **Mundipharma Medical Company** (shareholder of) — https://whiteintel.dev/entity/1f83255c-2875-53ba-b26c-d92c0408a686

## Provenance

- ICIJ Offshore Leaks — https://offshoreleaks.icij.org/nodes/80001595

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Kelly Pharmaceuticals Limited**. Human view: https://whiteintel.dev/entity/bfb812e9-9be6-5735-8510-b167c648480a · Structured JSON: https://whiteintel.dev/api/public/dossier/bfb812e9-9be6-5735-8510-b167c648480a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._